Science Explorer Back to mapMap
Discussion
Company · São Paulo · Brazil

Fleury S.A. (Brazil)

In research, Fleury S.A. (Brazil) stands highest in Medicine (#3,497 of 8,541 worldwide) and Health Sciences (#4,328 of 9,902 worldwide), 2022-now.

World rank, 2022-now
#12,915
of 22,385 · #13,985 all time
Rank in Brazil
#493
of 684
Research works
701
▲ 47% vs 2018-21
Citations
7.9k
11.2 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
vs its own fields
0.93×
1.00× is exactly expected
Open access
61%
world 40%
International
18%
world 18%

What is Fleury S.A. (Brazil) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #3,497 of 8,541 7.9%157 #3491
Health SciencesDomain #4,328 of 9,902 7.8%164 #4329

Each strip is that field's whole ranked pool, with the notch where Fleury S.A. (Brazil) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Fleury S.A. (Brazil) work in?

In 2022-now, 71% of research at Fleury S.A. (Brazil) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (68%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%). It does 3.0× the world's share of Health Sciences.

Health Sciences: 180 fractional works · 70.8% of its workMedicine: 173 fractional works · 68.1% of its workSurgery: 17 fractional works · 6.5% of its workHematology: 15 fractional works · 5.8% of its workOncology: 13 fractional works · 5.1% of its workPulmonary and Respiratory Medicine: 12 fractional works · 4.9% of its workEpidemiology: 11 fractional works · 4.4% of its workPublic Health, Environmental and Occupational Health: 11 fractional works · 4.2% of its workGenetics: 11 fractional works · 4.1% of its workPhysiology: 10 fractional works · 4.1% of its workInfectious Diseases: 9 fractional works · 3.6% of its workCardiology and Cardiovascular Medicine: 8 fractional works · 3.2% of its workRadiology, Nuclear Medicine and Imaging: 8 fractional works · 3.1% of its workPathology and Forensic Medicine: 8 fractional works · 3.0% of its workRheumatology: 6 fractional works · 2.4% of its workPediatrics, Perinatology and Child Health: 4 fractional works · 1.6% of its workNeurology: 4 fractional works · 1.5% of its workOrthopedics and Sports Medicine: 4 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 4 fractional works · 1.4% of its workNephrology: 2 fractional works · 1.0% of its workDermatology: 2 fractional works · 0.9% of its workObstetrics and Gynecology: 2 fractional works · 0.8% of its workHepatology: 2 fractional works · 0.8% of its workBiochemistry: 2 fractional works · 0.7% of its workReproductive Medicine: 2 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 0.5% of its workOphthalmology: 1 fractional works · 0.5% of its workEmergency Medicine: 1 fractional works · 0.3% of its workPharmacology: 1 fractional works · 0.3% of its workGastroenterology: 1 fractional works · 0.3% of its workOtorhinolaryngology: 1 fractional works · 0.3% of its workPsychiatry and Mental health: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workHealth Professions: 4 fractional works · 1.7% of its workGeneral Health Professions: 3 fractional works · 1.1% of its workHealth Information Management: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workDentistry: 1 fractional works · 0.5% of its workOral Surgery: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNursing: 1 fractional works · 0.3% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workVeterinary: 1 fractional works · 0.2% of its workLife Sciences: 45 fractional works · 17.9% of its workBiochemistry, Genetics and Molecular Biology: 29 fractional works · 11.4% of its workMolecular Biology: 10 fractional works · 4.1% of its workGenetics: 10 fractional works · 3.9% of its workCancer Research: 4 fractional works · 1.8% of its workEndocrinology: 1 fractional works · 0.5% of its workClinical Biochemistry: 1 fractional works · 0.5% of its workCell Biology: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.4% of its workImmunology and Microbiology: 11 fractional works · 4.2% of its workImmunology: 6 fractional works · 2.4% of its workVirology: 2 fractional works · 0.9% of its workParasitology: 1 fractional works · 0.4% of its workMicrobiology: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 3 fractional works · 1.2% of its workForestry: 1 fractional works · 0.4% of its workPlant Science: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNeuroscience: 2 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workSocial Sciences: 17 fractional works · 6.8% of its workSocial Sciences: 9 fractional works · 3.7% of its workEducation: 4 fractional works · 1.5% of its workSociology and Political Science: 4 fractional works · 1.4% of its workHealth: 1 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 4 fractional works · 1.7% of its workEconomics and Econometrics: 4 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 2 fractional works · 0.7% of its workManagement of Technology and Innovation: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.3% of its workArts and Humanities: 1 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workPhysical Sciences: 12 fractional works · 4.6% of its workEngineering: 4 fractional works · 1.7% of its workBiomedical Engineering: 4 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 4 fractional works · 1.5% of its workArtificial Intelligence: 2 fractional works · 0.8% of its workInformation Systems: 2 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 2 fractional works · 0.7% of its workManagement, Monitoring, Policy and Law: 1 fractional works · 0.3% of its workEcology: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.0% of its workALL ITS WORKFleury S.A.(Brazil)254fractional works, 2022-now
Life Sciences18%Physical Sciences5%Health Sciences71%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Medicine17368.1%
    2. Health Professions41.7%
    3. Dentistry10.5%
    4. Nursing10.3%
    5. Veterinary10.2%
    1. Biochemistry, Genetics and Molecular Biology2911.4%
    2. Immunology and Microbiology114.2%
    3. Agricultural and Biological Sciences31.2%
    4. Neuroscience21.0%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Social Sciences93.7%
    2. Economics, Econometrics and Finance41.7%
    3. Business, Management and Accounting20.7%
    4. Arts and Humanities10.3%
    5. Decision Sciences10.2%
    6. Psychology00.2%
    1. Engineering41.7%
    2. Computer Science41.5%
    3. Environmental Science20.7%
    4. Chemistry00.2%
    5. Physics and Astronomy00.2%
    6. Mathematics00.1%
    7. Materials Science00.1%
    8. Chemical Engineering00.0%
    9. Earth and Planetary Sciences00.0%
    10. Energy00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.24× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.14× its world share, 29 worksBiochemistry, Geneti…Immunology and Microbiology: 4.16× its world share, 11 worksImmunology and Micro…Neuroscience: 0.60× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.37× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.09× its world share, 0 worksChemical EngineeringChemistry: 0.11× its world share, 0 worksChemistryComputer Science: 0.19× its world share, 4 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.01× its world share, 0 worksEnergyEngineering: 0.12× its world share, 4 worksEngineeringEnvironmental Science: 0.14× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.03× its world share, 0 worksMaterials ScienceMathematics: 0.11× its world share, 0 worksMathematicsPhysics and Astronomy: 0.08× its world share, 0 worksPhysics and AstronomyDentistry: 0.99× its world share, 1 worksDentistryHealth Professions: 0.63× its world share, 4 worksHealth ProfessionsMedicine: 3.54× its world share, 173 worksMedicineNursing: 0.67× its world share, 1 worksNursingVeterinary: 1.66× its world share, 1 worksVeterinaryArts and Humanities: 0.10× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.22× its world share, 2 worksBusiness, Management…Decision Sciences: 0.24× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.78× its world share, 4 worksEconomics, Econometr…Psychology: 0.06× its world share, 0 worksPsychologySocial Sciences: 0.30× its world share, 10 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Immunology and Microbiology4.16×11 works
  2. Medicine3.54×173 works
  3. Biochemistry, Genetics and Molecular Biology2.14×29 works
  4. Veterinary1.66×1 works
  5. Dentistry0.99×1 works
  6. Economics, Econometrics and Finance0.78×4 works
  7. Nursing0.67×1 works
  8. Health Professions0.63×4 works
  9. Neuroscience0.60×2 works
  10. Pharmacology, Toxicology and Pharmaceutics0.37×0 works
  11. Social Sciences0.30×10 works
  12. Agricultural and Biological Sciences0.24×3 works
  13. Decision Sciences0.24×1 works
  14. Business, Management and Accounting0.22×2 works
  15. Computer Science0.19×4 works
  16. Environmental Science0.14×2 works
  17. Engineering0.12×4 works
  18. Chemistry0.11×0 works
  19. Mathematics0.11×0 works
  20. Arts and Humanities0.10×1 works
  21. Chemical Engineering0.09×0 works
  22. Physics and Astronomy0.08×0 works
  23. Psychology0.06×0 works
  24. Materials Science0.03×0 works
  25. Earth and Planetary Sciences0.01×0 works
  26. Energy0.01×0 works

Who are the top researchers at Fleury S.A. (Brazil)?

Ranked on the quality score, Luciana Pardini Chamié, Maria Carolina Tostes Pintão and Miguel Mitne‐Neto lead among researchers whose main affiliation is Fleury S.A. (Brazil).

  1. 1 Luciana Pardini Chamié Brazil · #433,792 worldwide 1.7k citations · 67 works
  2. 2 Maria Carolina Tostes Pintão Brazil · #1,341,161 worldwide 2k citations · 33 works
  3. 3 Miguel Mitne‐Neto Brazil · #1,387,677 worldwide 2.9k citations · 61 works
  4. 4 Karina Helena Morais Cardozo Brazil · #1,652,035 worldwide 2.8k citations · 79 works
  5. 5 Isabela Azevedo Nicodemos da Cruz Brazil · #1,855,319 worldwide 328 citations · 24 works
  6. 6 Adriana Lebkuchen Brazil · #2,057,266 worldwide 375 citations · 16 works
  7. 7 Júlio Brandão Guimarães Brazil · #2,212,759 worldwide 1k citations · 83 works
  8. 8 Wagner Antonio da Rosa Baratela Brazil · #2,219,929 worldwide 803 citations · 46 works
  9. 9 Alípio Gomes Ormond Filho Brazil · #2,386,000 worldwide 552 citations · 47 works
  10. 10 Valdemir Melechco Carvalho Brazil · #2,391,810 worldwide 2.6k citations · 123 works
All ranked researchers at Fleury S.A. (Brazil)

What are the most cited papers from Fleury S.A. (Brazil)?

The most cited paper from Fleury S.A. (Brazil) is "Evolution and epidemic spread of SARS-CoV-2 in Brazil" (Darlan S. Candido et al., 2020), with 658 citations. Next come "Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis" (521) and "An Unusually High Prevalence of Ocular Toxoplasmosis in Southern Brazil" (446).

Most cited papers
#PaperReleasedCitations
1 Evolution and epidemic spread of SARS-CoV-2 in Brazil Darlan S. Candido et al. · Science Open access 23 Jul 2020 658
2 Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis Maurício Simões Abrão, Manoel Orlando Gonçalves, José Augusto de Carvalho Dias et al. · Human Reproduction 18 Oct 2007 521
3 An Unusually High Prevalence of Ocular Toxoplasmosis in Southern Brazil Peter D. Glasner, Cláudio Silveira, Deanna Kruszon-Moran et al. · American Journal of Ophthalmology Aug 1992 446
4 The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography Patrizio Lancellotti, Patricia A. Pellikka, Werner Budts et al. · European Heart Journal - Cardiovascular Imaging Open access 21 Oct 2016 439
5 Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial Viviane Cordeiro Veiga et al. · BMJ Open access 20 Jan 2021 407
All 60 most cited papers, with filters and sorting

Which keywords describe research at Fleury S.A. (Brazil)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Prognostic Factors, Genetic Mutations, Rituximab, Diagnosis, Chemotherapy, Treatment and Hematopoietic Stem Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology31▲ 3.1×79 topics
  2. Prognostic Factors18▲ 17×12 topics
  3. Diagnosis12▲ 4.9×30 topics
  4. Treatment11▲ 3.7×31 topics
  5. Genetic Mutations10▲ 9.5×18 topics
  6. Inflammation10▲ 1.95×36 topics
  7. Rituximab10▲ 28×4 topics
  8. Chemotherapy10▲ 5.4×19 topics
  9. Immunotherapy8▲ 4.4×18 topics
  10. Quality of Life8▲ 2.2×20 topics
  11. Pathogenesis7▲ 5.7×18 topics
  12. Public Health7▲ 1.92×19 topics
  13. Hematopoietic Stem Cells7▲ 32×3 topics
  14. Therapeutic Targets7▲ 18×2 topics
  15. Chronic Lymphocytic Leukemia7▲ 64×1 topic
  16. Genomic Aberrations7▲ 64×1 topic
  17. Prognosis6▲ 7.5×8 topics
  18. Targeted Therapy6▲ 11×5 topics
  19. Breast Cancer6▲ 9.7×10 topics
  20. Clinical Practice Guidelines6▲ 4.3×13 topics
  21. Lymphoma6▲ 14×4 topics
  22. Precision Medicine6▲ 4.6×6 topics
  23. Immune Response6▲ 4.0×16 topics
  24. AML6▲ 44×1 topic
  25. Acute Myeloid Leukemia6▲ 44×1 topic
  26. Cardiovascular Risk5▲ 5.7×8 topics
  27. Radiotherapy5▲ 4.6×10 topics
  28. Vaccine5▲ 4.5×9 topics
  29. Mutation4▲ 9.9×4 topics
  30. PET Imaging4▲ 10×4 topics
  31. Pathophysiology4▲ 6.0×7 topics
  32. Viral Transmission4▲ 13×4 topics
  33. Infection4▲ 6.7×5 topics
  34. Minimal Residual Disease4▲ 24×2 topics
  35. Vaccine Development4▲ 6.4×10 topics
  36. Autoantibodies4▲ 6.8×8 topics
  37. Survival Analysis4▲ 5.7×6 topics
  38. Cell-Free DNA4▲ 15×2 topics
  39. Prenatal Diagnosis3▲ 9.1×5 topics
  40. Molecular Profiling3▲ 14×3 topics

Which research topics does Fleury S.A. (Brazil) publish most on?

By volume in 2022-now: Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 7 works
  2. 2 Acute Myeloid Leukemia Research Hematology 6 works
  3. 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 3 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 3 works
  7. 7 T-cell and Retrovirus Studies Immunology 2 works
  8. 8 Nutrition and Health in Aging Physiology 2 works
  9. 9 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  10. 10 Multiple Myeloma Research and Treatments Hematology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.8%not open39.2%

World: 40% of research is openly available.

with international co-authors17.7%domestic only82.3%

World: 18% is written across borders.

How has Fleury S.A. (Brazil)'s research output changed?

Output in 2022-2025 was 47% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Fleury S.A. (Brazil) as a percentage of every work published that year, 0.0011% in 2024.

still counting0.00050%0.0010%0.0015%Fleury S.A. (Brazil)0.00096% in 20251990200020102020

Fractional works of Fleury S.A. (Brazil) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting5%10%15%all institutions10.0% in 2025Fleury S.A. (Brazil)7.5% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 9.4% in 2013.

Other research institutions in São Paulo

All research institutions in São Paulo

Share Fleury S.A. (Brazil)'s ranking

Fleury S.A. (Brazil) on Science Explorer

A card with Fleury S.A. (Brazil)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Fleury S.A. (Brazil). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.